As leaders in the field of anticoagulant therapy, the Anticoagulation Forum has written the following guidance on inpatient and outpatient care.
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum
May 2022 issue of the Journal of Thrombosis & Thrombolysis
Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic Guidance
May 2020 issue of the Journal of Thrombosis and Thrombolysis
"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy”: Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG. 03.05.01 Elements of Performance
March 2020 issue of the Joint Commission Journal on Quality and Patient Safety
Reversal of Direct Oral Anticoagulants: Guidance from the Anticoagulation Forum
April 2019 issue of American Journal of Hematology
View Video Abstract
Management of Venous Thromboembolism: Clinical Guidance from the Anticoagulation Forum
January 2016 issue of the Journal of Thrombosis & Thrombolysis
Delivery of Optimized Inpatient Anticoagulation Therapy: Consensus Statement from the Anticoagulation Forum
May 2013 issue of The Annals of Pharmacotherapy
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
July/August 2008 issue of The Annals of Pharmacotherapy
The January 2016 edition of the Journal of Thrombosis and Thrombolysis features clinical guidance, published by members of AC Forum’s board of directors, on managing VTE.
View Press Release
View Manuscripts